AZD5672
AZD5672 is a pharmaceutical drug with 8 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 8 completed trials
Phase Distribution
Phase Distribution
7
Early Stage
1
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
8 of 8 finished
0.0%
0 ended early
0
trials recruiting
8
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin
AZD5672 Absolute Bioavailability Study
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart
Clinical Trials (8)
A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis
Drug Interaction Study - Effect of AZD5672 on the Pharmacokinetics of Digoxin
AZD5672 Absolute Bioavailability Study
Drug Interaction Study - Assess Pharmacokinetics of Both AZD5672 and Atorvastatin
A Study to Investigate the Potential for AZD5672 to Affect the Electrical Conduction Pathways in the Heart
AZD5672 Bioavailability Study in Healthy Male and Female Subjects
Safety Study of AZD5672 in Renally Impaired Subjects
Mass Balance and Metabolic Profiling of [14C]AZD5672 in Healthy Male Volunteers
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8